Key Details of Earnings Call
- Date: Wednesday, November 4, 2026
- Time: 2:30 PM to 3:30 PM IST
- Purpose: To discuss unaudited financial results for the quarter and half-year ended September 30, 2026
Participation Details
Pre-registration: Required via Diamond Pass link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0896694&linkSecurityString=7ead26c2c
Dial-in Numbers:
- Universal Dial-in Number (India): +91 22 6280 1488 / +91 22 7115 8869
- Hong Kong Local Access Number: 800 964 448
- Singapore Local Access Number: 800 101 2045
- UK Local Access Number: 0 808 101 1573
- USA Local Access Number: 1 866 746 2133
Participants will receive dial-in numbers, passcode, and PIN on their registered email address after pre-registration.
Management Contacts
- Bhagwat Singh Deora, Chief Financial Officer, Email: bhagwat.deora@evonilepharma.com
- Jason D'Souza, President – BD, M&A and IR, Email: jason.dsouza@evonilepharma.com
Additional Information
- The schedule is subject to change due to exigencies
- The announcement is a follow-up to the intimation dated September 30, 2026, regarding the Board Meeting for results approval
- The document is signed by Chandni Bhupendra Maru, Company Secretary and Compliance Officer (ACS A60291)
- The company website www.evonilepharma.com also provides access to register for the conference call